Novo Nordisk (NVO) Outperforms Broader Market: What You Need to KnowZacks Investment Research • 04/28/25
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, OzempicCNBC • 04/25/25
Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock?Zacks Investment Research • 04/24/25
Novo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity PillInvestors Business Daily • 04/22/25
Think It's Too Late to Buy Novo Nordisk? Here's the Biggest Reason Why There's Still Time.The Motley Fool • 04/22/25
Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (April 2025)24/7 Wall Street • 04/21/25
Novo Nordisk May Lag Behind Eli Lilly In Cardiometabolic Race, Analyst Downgrades StockBenzinga • 04/17/25
NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study SetbackZacks Investment Research • 04/15/25